Market research
002019.SHE Yifan Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 12B
- P/E ratio
- 38.36
- Analyst target
- 13
- Dividend yield
- 1.0%
- Beta
- 0.45
Community
Investor discussion
1 comment
Sign in to join the 002019.SHE discussion.
5 years, 5 months ago
Yifan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 18.4% below its 200 day moving average.
From a valuation standpoint, the stock is 52.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.
Yifan Pharmaceutical Co., Ltd's total revenue sank by 9.5% to $1B since the same quarter in the previous year.
Its net income has dropped by 64.6% to $57M since the same quarter in the previous year.
Finally, its free cash flow fell by 236.5% to $-210M since the same quarter in the previous year.
Based on the above factors, Yifan Pharmaceutical Co., Ltd gets an overall score of 1/5.